Advertisement Feature

The University of Notre Dame Australia has gained a reputation for ground-breaking collaborative research designed to help those facing challenging circumstances.

Though a young institution, Edith Cowan University has rapidly transformed from purely teaching beginnings to applied research that is making a difference.

The University of Western Australia taps into one of the world’s richest reservoirs of resources to develop exceptional research programmes

As Western Australia’s largest and most internationally engaged university, Curtin University continues to build influential research collaborations that strike a balance between demand-driven and researcher-driven research

Spirometry is the only method to definitively diagnose COPD, but two-thirds of patients go untested. A look at the state of an undervalued diagnostic.

Located in Australia’s largest city, Western Sydney University is producing research with global ramifications.

With significant new investments in biomedical technology, Indiana University is recruiting faculty to work at the leading edge of precision health

Advanced courses and scientific conferences at the Wellcome Genome Campus celebrates 30 years of training in genomics and biomedicine.

A conversation with Aaron Elliott, CEO of Ambry Genetics

Building a path between fundamental science, diagnosis, and therapy, translational medicine is a rapidly developing field demanding multidisciplinary collaboration. Aiming to integrate resources and bridge academia, clinical, pharmaceutical and investment industries, the Translational Medicine Forum of Innovation and Collaboration (TMIC), recently held in Shanghai, China, provides a platform for people of different industries to discuss the collaboration needed to drive biomedical innovation.

The Nano Life Science Institute (NanoLSI) at Kanazawa University is recruiting postdoctoral researchers for a place at the forefront of the nanobiosciences.

The Japan Advanced Institute of Science and Technology (JAIST) has created an environment for nurturing true intellectual rigour

Kanazawa University started in 1862 as a smallpox vaccination centre. It is now making its mark through world-leading advances in nanotechnology, human health, environmental sciences and other fields.

Shibuya Corporation is promoting the industrialization of regenerative medicine and contributing to society through its aseptic and automated technologies

The old paradigm of giving the same drug to all patients is being supplanted by a new one that includes co-opting individual patients’ own cells to fight disease. Researchers at Kanazawa Medical University are spearheading the era of personalized medicine by developing treatments that harness the power of immune cells and stem cells.

Growth factors (GFs) constitute a large and versatile family of signalling proteins that govern cell growth, division and survival, and therefore have great potential as therapeutics. At Wenzhou Medical University (WMU), researchers in the School of Pharmaceutical Sciences are spearheading basic GF research, and the development of novel biological drugs.

The School of Ophthalmology and Optometry at Wenzhou Medical University (WMU) has great vision in its field. Among its breakthroughs is the first proof that scleral hypoxia — a lack of oxygen in the white of the eye — can cause myopia. Their hypothesis has led to new treatments.

In the 60 years since it was established, Wenzhou Medical University (WMU), located in eastern China’s Zhejiang province, has made great advances in talent training, research capacity building and medical services.

Severe acute pancreatitis can be lethal and has grave potential to cause complications, harming other vital organs. At the First Affiliated Hospital of Wenzhou Medical University (WMU), clinical faculty members have developed a comprehensive treatment system that reduces the mortality rate of this dangerous disease from 14.4% to 4.6%.

The Second Affiliated Hospital of Wenzhou Medical University (WMU) is leading a digital revolution for patient access. It is among China’s first to pilot the ‘cloud hospital’ platform, which lets patients make appointments, renew prescriptions, apply for admission, among other services, all from home. Its uptake of mobile and paperless healthcare has seen it collect the highest daily settlement amount of RMB 2.1 million ($305,659) on Alipay, China’s popular online payment platform, which tops Chinese hospitals and is indicative of patient preference of such streamlined processes.